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1. INTRODUCTION AND REVIEW OF LITERATURE 
1.1. Genetic vulnerability and environmental  
factors in alcohol use disorders 
1.1.1. Harm of alcohol use disorders 
Problematic use of alcohol is one of the leading causes of preventable deaths 
and disability. According to the Global Burden of Disease Study 2013, alcohol 
use continues to be a major contributor to disease burden worldwide (Degen-
hardt et al. 2016). Alcohol consumption is a causal factor in more than 200 
disease and injury conditions, causing death and disability relatively early in 
life: In the age group 20–39 years approximately 25% of the total deaths are 
alcohol-attributable (WHO 2014). Based on the harm to the individual and 
others, alcohol was considered to be the most harmful drug in UK (Nutt et al. 
2010). For men in Eastern Europe, the highest loss of disability adjusted life 
years (DALYs) due to mental disorders has been attributed to alcohol abuse 
(Wittchen et al. 2011). According to the data presented by the Organisation for 
Economic Co-operation and Development (OECD) in their 2015 economics and 
public health policy report, Estonia is one of the largest consumers of pure 
alcohol of all its member states (OECD 2015). The chronic and relapsing nature 
of alcoholism is the reason why the search for predictive biomarkers to help 
clinicians select and monitor a therapeutic course of action and to help 
researchers evaluate new therapeutic interventions is so urgent (Volkow and 
Baler 2013). 
 
 
1.1.2. Vulnerability factors for alcohol use disorders 
1.1.2.1. Genetic vulnerability 
The fundamental goal of neuroscience is to understand the neurobiological 
mechanisms that shape the behaviour. Genetic factors mediate sensitivity to the 
pathogenic effects of environmental risk factors through control of, sensitivity 
to, and exposure to the environment (Kendler and Prescott 2006). The inborn 
differences in the activity of several neurotransmitter systems are one important 
reason why alcohol consumption differs between individuals (Kimura and 
Higuchi 2011). Heaviness of alcohol consumption and dependence symptoms 
have a high degree of genetic overlap, implying that genetic influences on 
dependence risk in the general population are acting to a considerable degree 
through heaviness of use, and that quantitative measures of consumption will 
likely have a useful role in the identification of gene variants contributing to 
alcohol dependence (Grant et al. 2009). Evidence from family, adoption, and 
twin studies converges on the relevance of heritability on substance use and 
addiction with estimates ranging from 0.39 to 0.72 (Goldman et al. 2005). 
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Identification of specific genes conveying increased risks of drug use has promise 
not only for understanding the causes and potential treatments for disease, but 
also for increasing our knowledge of how genetic and environmental risks 
interact to shape liability to addiction (Agrawal and Lynskey 2008).  
However, according to evidence from genome-wide association studies 
(GWAS), the contribution of individual genetic variants to the risk for alcohol-
related disorders is small, probably due to gene-environment interactions 
(G × E) (Samochowiec et al. 2014). G × E are defined as different expression of 
a gene across environments or equivalently, the effect of the environment 
varying on the observed phenotype by genotype (Gunzerath and Goldman 
2003). Some of the signals that emerge from GWAS may turn out to reflect the 
action of modifiable (e.g., environmental or behavioural) exposures, rather than 
more direct biological effects (Gage et al. 2016). 
 
 
1.1.2.2. Environmental stressors 
Exposure to stress has been described as an important component in high risk 
for drug use (Balk et al. 2009; Keyes et al. 2011a; Stogner and Gibson 2013). 
Since Caspi and colleagues’ seminal study (2002), research on individual dif-
ferences in genetic susceptibility to stressful experiences have gained momentum 
as an important factor that amplifies a host of negative behavioural and psycho-
logical outcomes for youth (Stogner and Gibson 2013).  
Common stressful life events (SLEs) significantly influence substance use 
and mental health symptoms (Balk et al. 2009; Booker et al. 2008; Nation and 
Heflinger 2006). SLEs are described as discrete quantifiable circumstances that 
can have severe negative impact (Low et al. 2012). SLEs have been linked to 
the level of substance use and increases in use over time (Wills et al. 2001). 
Specifically, cumulative exposure to adversities such as domestic violence, 
physical, emotional and sexual abuse, neglect, and parental dysfunction due to 
alcohol or drug use increases propensity for drug use disorders across life span 
(reviewed by Myers et al. 2014). High emotional stress that can result from such 
events has been associated with the loss of control over impulses and an 
inability to inhibit inappropriate behaviours and to delay gratification (Mischel 
et al. 1989).  
 
 
1.1.2.3. The role of gender 
Women generally drink less alcohol and have fewer alcohol-related problems 
than men (World Health Organization 2014). Yet some studies suggest that, in 
recent decades, the gender difference in drinking- and alcohol-related problems 
has decreased (MacArthur et al. 2012; Wagoner et al. 2012; Wilsnack et al. 
2009). It is acknowledged that alcohol use problems are more likely in people 
who start drinking at an early age and that drinking problems are on the rise, in 
particular in girls, and especially in Northern and Eastern Europe and in the 
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USA (Keyes et al. 2008; Wilsnack and Wilsnack 2013). A cohort-specific 
increase in female drinking would signal the need for better targeted prevention 
and intervention efforts to address drinking problems (Keyes et al. 2011a). 
 
 
1.1.2.4. Birth cohort effects 
Alcohol consumption has been shown to be subject to birth cohort effects 
(Johnson and Gerstein 1998; Pabst et al. 2010; Rice et al. 2003). Birth cohort 
effects reflect the socioeconomic environment experienced by different genera-
tions. Economic fluctuation, political instability, policies and laws, social norms 
and awareness are group-level exposures that can vary between time periods 
and countries (Keyes et al. 2011a), potentially impacting particular birth cohorts 
in ways that affect their risk for earlier or more frequent drug use and substance 
use disorders. Restrictions, prices, and advertisements related to alcohol directly 
influence drinking behaviour at younger ages (Paschall et al. 2009), which tends 
to predict patterns of alcohol use over the life course (Pitkanen et al. 2005; 
Eliasen et al. 2009). Recent studies on alcohol consumption trends have found 
that birth cohorts are significant explanatory factors (Meng et al. 20014; Kraus 
et al. 2015). Using data from several European countries, the inclusion of the 
birth cohort dimension has been shown to improve the understanding of 
alcohol-attributable health problems in both males and females (Trias-Llimós et 
al. 2016). This dimension has however not been included in G × E studies so far. 
Countries of Central and Eastern Europe (CEE) are very often referred to as 
transition societies. Here, transition societies are former socialist countries under-
going a process of democratisation. The term refers to a situation in which the 
political structure is changing from a single-party rule to a parliamentary system, 
administrative institutions are being reorganized, central planning is changing to 
a capitalist free market economy and a society of shortages is changing to a con-
sumer society (Allaste and Bennet 2013; Nugin et al. 2016). Estonia is a repres-
entative CEE transition society that moved away from socialism in the late 
1980s and became an independent and highly liberal economy since 1991. The 
Estonian economy was one of the fastest growing in the world until 2007 
(World Bank 2015), bringing about rapid but multifaceted social changes. As 
described by Allaste and Bennet (2013), Soviet-type regimes strived for homo-
genisation of their populations in regard of lifestyle; post-socialist trans-
formation turned them into participants of the global lifestyle market. The idea 
of citizens as autonomous contract-making individuals did not emerge from 
capitalism of its own accord, it has been a subject of struggles over ways of life 
and the distribution of freedoms over two and a half centuries of capitalist 
development (Sulkunen 2009). A distinguishing characteristic of a transition 
society is the discrepancy between the speed of institutional reform and the 
slowness of cultural changes and liminality – the sense of being in between the 
two social orders (Allaste and Bennet 2013). However, the former socialist 
countries – including Estonia – missed the process of the most relevant develop-
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ments of the twentieth century (e.g., orientation towards consumerism and leisure, 
privatization and free market economy, diversity of lifestyles and visibility of 
alternative subcultures), starting from the 1960s, and have been adopting the 
Western lifestyle only in the last two and a half decades with vigor at enhanced 
speed. Therefore, if present, the cohort effects could be observable within a 
relatively brief time span. 
 
 
1.2. Candidate genes for alcohol use disorders 
1.2.1. Serotonin transporter gene and  
its role in alcohol use disorders 
The level of 5-HT in the synaptic clefts throughout the brain is mainly regulated 
by the 5-HT transporter (5-HTT) (Voineskos et al. 2007). 5-HTT carries out the 
reuptake of serotonin from the synaptic cleft, terminating neurotransmission and 
restoring serotonin reserves in presynaptic terminals. The human 5-HTT gene 
contains a polymorphic region (5-HTTLPR) with two functional variants: a 
short (s) allele consisting of 14 tandem repeats and having low transcriptional 
efficiency, and a long (l) allele consisting of 16 tandem repeats and having high 
transcriptional efficiency (Lesch et al. 1996). In addition, an A/G nucleotide 
substitution in the l allele (rs25531) renders the 5-HTTLPR tri-allelic, with the 
lg allele functionally equivalent to the s allele in vitro (Hu et al. 2006; Jasinska 
and Perkins 2009).  
Carriers of the s allele display increased reactivity of the amygdala to fearful 
stimuli (Hariri et al. 2002), reduced amygdalar (Pezawas et al. 2005) and hippo-
campal volume (Everaerd et al. 2012), and enhanced functional coupling between 
the amygdala and the ventromedial prefrontal cortex (Heinz et al. 2005). Low-
expressing allele carriers who experience stressful life events have been found 
to have a higher risk of depression (Caspi et al. 2003). On the other hand, low-
expressing allele carriers often respond more positively to environmental 
enrichment than high-expressing allele homozygotes (Belsky et al. 2009). Such 
“hypervigilance” may be moderately harmful in the day-to-day, but highly 
beneficial for survival under circumstances that have major impacts on fitness, 
such as when life-threatening situations arise (Dobson and Brent 2013; Hom-
berg and Lesch 2011). 
The role of serotonin in alcohol consumption has been studied in animal 
models. Serotonergic system has been found to have only a minor role in 
mediating sensitivity to high doses of alcohol (reviewed by Vengeliene et al. 
2008), but to be crucial for the development of alcohol reinforcement. It has 
been shown that alcohol potentiates the action of 5-HT (Lovinger and Zhou 
1994), and it has been suggested that inborn serotonergic dysfunction might be 
of importance for the initial alcohol preference. Low levels of 5-HT in limbic 
structures have been identified in several alcohol-preferring rat lines (McBride 
and Li 1998). In humans, lower activity of platelet monoamine oxidase (MAO), 
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a marker for the central serotonergic system (Oreland 2004), has been demon-
strated in chronic alcoholic patients and associated with alcohol-related problem 
behaviour (Eensoo et al. 2004; Nilsson et al. 2008; Pivac et al. 2004; Schmidt et 
al. 1997).  
A number of studies have investigated the role of 5-HTTLPR in alcohol 
consumption, with contradictory results (reviewed by Dick and Foroud 2003; 
McHugh et al. 2010). In some studies, an association between the short allele of 
5-HTTLPR and higher alcohol consumption (Covault et al. 2007; van der 
Zwaluw et al. 2010; Merenäkk et al., 2011), alcohol dependence (Feinn et al. 
2005; Hallikainen et al. 1999; Hammoumi et al. 1999; Lichtermann et al. 2000; 
McHugh et al. 2010; Sander et al. 1997) or binge drinking (Matsushita et al. 
2001) has been detected. In others, the long 5-HTTLPR allele has been found to 
be associated with earlier onset of alcohol use (Twitchell et al. 2001) and 
dependence (Ishiguro et al. 1999), alcoholism (Parsian and Cloninger 2001; 
Philibert et al. 2008; Schuckit et al. 1999), and compulsive craving in alcohol 
dependence (Bleich et al. 2007). In a study by Kaufman et al. (2007), hetero-
zygous children (l/s) were shown to have the greatest vulnerability to early 
alcohol use. Several other studies have found no evidence of association between 
5-HTTLPR and alcohol use (Edenberg et al. 1998; Köhnke et al. 2006; Preuss et 
al. 2000; Rasmussen et al. 2009; Shin et al. 2010; Thompson et al. 2010). This 
is not surprising, given that alcohol consumption is influenced by social, eco-
nomic, and political conditions that vary between countries and can vary within 
a country between time periods. Therefore, analyzing the effects of 5-HTTLPR 
genotype on alcohol use in the context of birth cohorts may shed light on the 
background of these varied results. 
 
 
1.2.2. Vesicular monoamine transporter 1 gene and  
its role in mental health disorders 
Two structurally related but pharmacologically distinct human vesicular 
monoamine transporters have been identified, encoded by separate genes, VMAT1 
(SLC18A1) located on chromosome 8p21 and VMAT2 (SLC18A2) on chromo-
some 10q25 (Peter et al. 1993). It was initially reported that only VMAT2 is 
expressed in the brain (Peter et al. 1995; Erickson et al. 1996). However, it was 
later found that VMAT1 is also widely expressed in human brain at the mRNA 
and protein level (Lohoff et al. 2006). VMATs carry monoamines such as 
serotonin, dopamine, adrenaline and noradrenaline from the cytoplasm into 
storage vesicles (Edwards 1992). The transporters share common substrates 
with the exception of histamine, which is believed to be preferentially packaged 
by VMAT2 (for review, see Bernstein et al. 2014). They also differ in affinities: 
VMAT1 shows higher affinity for serotonin (Brunk et al. 2006).  
Monoamine systems undergo extensive and interdependent functional reor-
ganization as affective disorders develop (e.g., Harro and Oreland 2001). Several 
functional polymorphisms in the monoaminergic (dopaminergic, serotonergic, 
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and noradrenergic) systems have been reported to moderate anxiety and affective 
disorders (for review, see Lacerda-Pinheiro et al. 2014) and alcohol use (Guo et 
al. 2007). Although deviations in monoaminergic function probably vary between 
disorders, a common source of vulnerability could lie in the vesicular function 
that controls monoamine storage and homeostasis. Studies in vitro show that 
lithium and valproate, effective pharmacotherapies for bipolar disorder, increase 
the expression of VMAT1, suggesting that the VMAT1 might be a target for 
therapeutic drug action (Lohoff 2010; Wimalasena 2011). Several recent genetic 
case-control studies have documented an association between common missense 
variations in the VMAT1 gene and susceptibility to bipolar disorder (Lohoff et 
al. 2006) and schizophrenia (Bly 2005; Chen et al. 2007; Lohoff et al. 2008a). 
A common single nucleotide polymorphism in the VMAT1 gene (rs1390938 
G/A) that results in threonine or isoleucine at amino acid 136 (Thr136Ile) has 
recently been shown to be functional in vitro, with the 136Ile variant leading to 
increased monoamine transport into presynaptic vesicles (Khalifa et al. 2012). 
Thr136Ile polymorphism is located in the intravesicular loop 1, and the fre-
quency of the hyperfunction allele (A; 136Ile) is ~0.25 in European and Cau-
casian samples and <0.1 in African samples.  
Carriers of the 136Ile (A) variant show diminished hemodynamic responses 
to negative emotional words in the medial prefrontal cortex and pregenual 
anterior cingulate cortex when compared with Thr136 homozygotes, suggesting 
that the VMAT1 hyperfunction allele may predispose certain individuals to a 
diminished cortical response to negative stimuli (Lohoff et al. 2014). An asso-
ciation of the 136Thr variant with bipolar disorder (Lohoff et al. 2006) and higher 
self-report State-Trait Anxiety Inventory (STAI) scores in Thr/Ile heterozygous 
females (Lohoff et al. 2008b) has also been described. Considering that symp-
toms of anxiety and depressiveness have been associated with problematic 
alcohol use (de Abreu Costa et al. 2013; Edwards et al. 2014), the possibility that 
the rs1390938 polymorphism has a role in alcohol consumption should be 
considered. 
 
 
1.2.3. Neuregulin-1 gene and its role in mental health disorders 
NRG1 is a signaling protein that affects neuronal survival and development, 
synaptic plasticity and glial functioning, and has been described as being critical 
for how an organism responds and adapts to the environment (Stefansson et al. 
2004). The gene encoding NRG1 is located on 8p12–21, and about 15 known 
NRG1 isoforms are generated through alternative promoter usage and splicing 
(Buonanno and Fischbach 2001; Falls 2003). These isoforms participate in neur-
onal migration and specification, oligodendrocyte differentiation and myelina-
tion, and regulation of cholinergic neurotransmission and expression of glutamate 
and γ-aminobutyric acid (GABA) receptors (Mei and Xiong 2008). NRG1 type 
IV has only been detected in brain and a putative type IV NRG1 protein of 66 
kDa is similarly brain-specific (Tan et al. 2007). A functional polymorphism in 
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the promoter region of the brain-specific type IV neuregulin-1 (NRG1) gene – 
SNP8NRG243177/rs6994992; (C/T) has recently become of target in mental 
health research.  
Frequency of the minor (T) allele of the rs6994992 polymorphism has been 
found to be ~0.35 in European samples (Barnes et al. 2012; Kéri 2009; McIntosh 
2008). The rs6994992 polymorphism affects NRG1 transcription rates: hippo-
campal mRNA expression of type IV NRG1 has been found to be higher in 
individuals carrying the T allele (Law et al. 2006). It has been confirmed by 
single point mutagenesis that promoter activity of the construct rs6994992-T is 
~65% higher than that of the construct rs6994992-C (Tan et al. 2007). This 
genetic variant has also been demonstrated to affect brain structure as the T 
allele was associated with decreased grey matter volume and white matter 
density (Barnes et al. 2012; McIntosh et al. 2008), and also with reduced white 
matter integrity (Sprooten et al. 2009) in several brain regions. 
NRG1 has originally been investigated as a candidate susceptibility gene for 
schizophrenia; the presence of the minor T allele has been associated with mental 
health problems. NRG1 was first associated with schizophrenia in the Icelandic 
population (Stefansson et al. 2002). The majority of subsequent association 
studies, including two in Scottish populations (Stefansson et al. 2003; Thomson 
et al. 2007) have shown association of NRG1 with both schizophrenia and bipolar 
disorder (Green et al. 2005), while the results have not been uniform (Crowley et 
al. 2008). In a genome-wide association study of alcohol dependence, the novel 
associations have suggested direct involvement of, or interaction with, genes 
previously identified as schizophrenia risk loci (Gelernter et al. 2014). In a 
genome-wide linkage and association study on an African-American sample it 
was found that NRG1 is a likely susceptibility gene for cannabis dependence 
(Han et al. 2012).  
Experimentally, it has been demonstrated that manipulation at the neure-
gulin-1 gene alters the sensitivity to the behavioural effects of cannabinoids: 
compared to wild type-like animals, heterozygous Nrg1 transmembrane-domain 
knockout mice were more sensitive to the sedative action of cannabinoids 
(Boucher et al. 2007a) and also to the effects of Δ9-tetrahydrocannabinol (THC) 
on stress response (Boucher et al. 2007b). Interestingly, partial deletion of Nrg1 
interacts with stress to promote neurobehavioural deficits, as Nrg1 heterozygous 
mice displayed greater acute stress-induced anxiety-related behaviour than wild-
type mice (Chohan et al. 2014).  
Results from an animal model and a genome-wide linkage and association 
study in humans suggest that NRG1 is a likely susceptibility gene for drug use. 
Given that individuals with schizophrenia and their non-psychotic siblings 
report higher rates of alcohol, cannabis, and nicotine use and that NRG1 
rs6994992 polymorphism has been associated with schizophrenia risk, the 
NRG1 genotype could also affect alcohol use. The rs6994992 polymorphism has 
been found to interact with psychosocial stress (Kéri et al. 2009b). 
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1.2.4. Oxytocin receptor gene and  
its role in alcohol use disorders 
Oxytocin, a nine amino acid neuropeptide (nonapeptide), is synthesized primarily 
in the magnocellular neurosecretory cells of the paraventricular and supraoptic 
nuclei of the hypothalamus, and stored in the posterior pituitary gland, but 
extensive pathways containing oxytocin are present already in teleosts and highly 
developed mesolimbic tracts exist in mammalians (Grinevich et al. 2016). High 
density of oxytocin receptors has been found in brain regions involved in 
regulating mood, social behaviour and addictive processes, such as the central 
nucleus of amygdala, nucleus accumbens and ventral pallidum (Gimpl and 
Fahrenholz 2001). Oxytocin is a potent modulator of a variety of brain functions 
including learning, memory, emotions, mood, sexual behaviour, and adapting to 
social environment (reviewed by Sarnyai 2011). 
There is accumulating evidence of an interaction between the neural sub-
strates of affiliative behaviour and those of drug reward (reviewed by McGregor 
and Bowen 2012), with a role for brain oxytocin systems in modulating acute 
and long-term drug effects (McGregor et al. 2008). Intranasal administration of 
oxytocin has been found to elicit a variety of physiological and behavioural 
effects in humans, including reduction of anxiety (de Oliveira et al. 2011), and 
plasma levels of oxytocin-reactive autoantibodies correlate with mood states 
(Garcia et al. 2011). However, these results should be interpreted with caution: 
it has recently been brought up that studies analyzing the effects of intranasally 
administered oxytocin are generally underpowered (Walum et al. 2016) and it is 
unclear what percentage of peripherally administered oxytocin reaches oxytocin 
receptors in the brain (Leng and Ludwig 2016). 
It has been suggested that anxiety disorders increase the risk for developing 
alcohol use disorders (Boschloo et al. 2013; Kessler et al. 1997). Oxytocin has 
been found to enhance functional connectivity between the amygdala and the 
bilateral insula and middle cingulate/dorsal anterior cingulate gyrus during the 
processing of fearful stimuli, suggesting that oxytocin may have broad prosocial 
implications such as enhancing the integration and modulation of social responses 
especially in anxiogenic contexts (Kirsch et al. 2005; Gorka et al. 2015). By 
reducing anxiety, increasing the ability to cope with stress, and possibly reversing 
established alcohol tolerance, oxytocin treatment may diminish craving and 
facilitate sobriety. Indeed, oxytocin treatment not only blocks alcohol with-
drawal in human subjects (Pedersen et al. 2013) but has also been shown to 
decrease alcohol preference in animals. Recent preclinical studies in rodents 
have reported a remarkable ability of exogenously delivered oxytocin to inhibit 
stimulant and alcohol self-administration, to alter associated drug-induced 
changes in dopamine, glutamate and Fos expression in cortical and basal ganglia 
sites, and to prevent stress- and priming-induced relapse to drug seeking (re-
viewed by McGregor and Bowen, 2012). Based on previous findings it can be 
hypothesized that susceptibility to alcohol abuse is affected by individual dif-
ferences in the oxytocinergic system.  
17 
The human oxytocin receptor gene (OXTR) is located on chromosome 3p25, 
spans about 17 kb, consists of three introns and four exons (Inoue et al. 1994), 
and encodes a 389-amino acid polypeptide with seven transmembrane domains 
belonging to the class I of the G-protein-coupled receptor family (Gimpl and 
Fahrenholz 2001). One of the common polymorphisms (rs53576) in the oxytocin 
receptor gene has recently been found to modulate the effect of oxytocin adminis-
tration (Feng et al. 2015): oxytocin increased the reward or salience of positive 
social interactions for male major allele (G) homozygotes, while decreasing 
those processes for female major allele (G) homozygotes. This single nucleotide 
polymorphism (SNP) of an adenine (A, f≈0.4) or guanine (G, f≈0.6) within the 
third intron (rs53576) appears as a particularly promising marker of inter-
individual differences in oxytocinergic function (Tost et al. 2010; Wu et al. 
2005). Although the molecular functionality of this SNP is still unknown (Feng 
et al. 2015), the A allele has been suggested to be associated with less efficient 
oxytocinergic functioning in experimental settings (Marsh et al. 2012), and this 
would be theoretically consistent with association studies: the A allele carriers 
have lower levels of optimism, mastery, and self-esteem (Saphire-Bernstein et 
al. 2011), lower general sociality (Li et al. 2015), empathy, and higher levels of 
stress reactivity (Rodrigues et al. 2009). Different OXTR polymorphisms have 
been found to moderate the effects of alcohol use on aggressive behaviour in 
males, suggesting that alcohol has a larger effect on aggressive behaviour for 
those who, due to altered oxytocin signaling, already in a sober state have more 
difficulties with social abilities (Johansson et al. 2012a, 2012b; LoParo et al. 
2016). 
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2. AIMS OF THE STUDY 
This dissertation comprises of analyses aimed to explore the effects of common 
neurotransmission-related genetic polymorphisms (involved in different psychi-
atric disorders and mediating the adaptation to the environment) in relation to 
alcohol use in a population-representative sample. 
 
More specifically, 
1.  Is the association of alcohol use and 5-HTTLPR genotype also present in 
the older birth cohort of the ECPBHS, and subject to cohort effects? (Paper 
I) 
2.  Does the VMAT1 rs1390938 polymorphism affect the rates of alcohol use 
and whether any eventual associations depend on gender, birth cohort and 
environmental factors? (Paper II) 
3.  Is the NRG1 rs6994992 polymorphism associated with rates of alcohol use 
and whether any eventual associations depend on gender, birth cohort and 
environmental factors? (Paper III) 
4.  Does the OXTR rs53576 polymorphism affect the rates of alcohol use and 
whether any of the associations depend on gender, birth cohort and environ-
mental factors? (Paper IV)  
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3. MATERIALS AND METHODS 
3.1. Study population 
Research in this dissertation is based on the ECPBHS sample. This is the original 
Estonian sample of the European Youth Heart Study (1998/99) which was sub-
sequently incorporated into the longitudinal Estonian Children Personality 
Behaviour and Health Study (ECPBHS). All the subjects are of Caucasian 
descent. The selection of the original sample and procedure of first data 
collection has been described in detail elsewhere (Harro et al. 2001). In brief, 
this is a representative sample of the Tartu city and county with a school as the 
sampling unit. All schools of Tartu County, Estonia, that agreed to participate 
(54 of the total of 56) were included into the sampling using the probability pro-
portional to the number of students of the respective age groups in the school, 
and 25 schools were selected. All children from grades 3 (younger birth cohort) 
and 9 (older birth cohort) were invited to participate.  
The total number of subjects in the first wave in 1998/99 was 1176 (45.7% 
males); 583 in the younger cohort (mean age=9.5, SD=0.5) and 593 in the older 
cohort (mean age=15.4, SD=0.6). The follow-up studies for the younger cohort 
took place in 2004 (n=483, mean age=15.3, SD=0.7), 2007 (n=454, mean 
age=18.3, SD=0.5) and 2014 (n=440, mean age=25.3, SD=0.5). For older cohort, 
the follow-ups were in 2001 (n=479, including 62 additional subjects, mean 
age=18.4, SD=0.9) and 2008 (n=541, mean age=24.7, SD=0.7). ECPBHS is 
population representative, while 79.1% of subjects of the randomized regional 
sample participated in the original sampling. The study was approved by the 
Ethics Review Committee on Human Research of the University of Tartu, and 
written informed consent was obtained from all the participants, and in case of 
minors, also from their parents. 
 
 
3.2. Measurements 
3.2.1. Estimation of alcohol consumption 
Data collection was performed in uniform conditions of the laboratory at each 
wave. The measures in questionnaires varied by study waves. Subjects reported 
the age when they first consumed half a unit of alcohol during all follow-up 
studies (Papers I, II and III). One unit of alcohol was defined as a glass of light 
wine or champagne (12 cl), a shot of vodka (4 cl), or a bottle (33 cl) of light 
alcohol (beer, long drink, cider, etc.). In all data collection waves the participants 
reported how often they had consumed different types of alcoholic beverages 
(Papers II, III and IV). According to the most frequently consumed type of 
alcoholic beverage, a 5-point total alcohol use scale was constructed: 1=almost 
never, 2=less than once a month, 3= at least once a month, 4= at least once a 
week, 5=every day, as previously described in Merenäkk et al. (2003). In Paper 
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I, data from the older birth cohort regarding the frequency of alcohol consump-
tion during the previous 30 days at ages 18 and 25 was utilized, using a seven-
point scale: 1=not at all, 2=once, 3=all together two to three times, 4=once or 
twice a week, 5=three to four times a week, 6=five to six times a week, and 
7=every day (Merenäkk et al. 2011). In Paper III, data from the older birth 
cohort regarding the frequency of consuming more than 5 units of alcohol at a 
time (i.e., binge drinking) during the previous 12 months at the age of 25 was 
analyzed, using a five-point scale similar to the one used in the case of the most 
frequently consumed type of alcoholic beverage. 
 
 
3.2.2. Use of tobacco products 
Smoking habits were also assessed in all waves (Paper III). The proportion of 
smokers at age 18 in both cohorts and at age 25 in the older birth cohort was 
analyzed. In addition, the frequency of consuming tobacco products during the 
previous 30 days in the older birth cohort at the age of 25 was included in the 
analysis. A six-point scale was used: 1=never, 2=once or twice a month, 3=once 
or twice a week, 4=almost every day, 5=every day, 6=several times a day. 
 
 
3.2.3. Illicit drug use 
Nine years old children were not asked about illicit drugs. In all other data 
collection waves, subjects of both birth cohorts reported whether they had ever 
used illicit drugs (Paper III). 
 
 
3.2.4. Psychiatric diagnosis 
Psychiatric assessment based on DSM-IV was carried out in the older cohort at 
age 25 by experienced clinical psychologists using the Mini-International Neuro-
psychiatric Interview (M.I.N.I.5.0.0; Sheehan et al. 1998; Estonian version: 
Shlik et al. 1999) at age 25. In the analysis we used lifetime incidence of affective 
and anxiety disorders (Paper II), and substance use disorders (Papers II, III 
and IV) which in our sample almost exclusively consisted of alcohol use 
disorder (AUD) (Laas et al. 2015). 
 
 
3.2.5. Stressful life events 
History of stressful life events (SLEs) was self-reported in all follow-up studies 
(Paper III). Subjects were divided into low (0–2 events) and high (3 or more 
events) SLE exposure groups (Laas et al. 2015). The list of adverse life events 
varied across measurement times and consisted of 10–17 (dependent on the study 
wave) stressful experiences including parental death and divorce/separation, 
unemployed parent, parental alcoholism, poverty, poor living conditions, poor 
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health, accidents and traumas, physical abuse, emotional abuse, severe burden/ 
serious concerns, suicidal attempts, leaving home for several days without telling 
anyone, depression of a close relative, suicide attempt or committed suicide of a 
close relative. The events were recorded as dichotomous variables (present or 
not present) and were then counted to form the number of adverse life events 
experienced. 
 
 
3.2.6. Social interactions 
Relationship with teachers, classmates and family members were self-reported 
at ages 15 and 18 (Paper IV). The ECPBHS Child Questionnaire included eleven 
items on perceived school atmosphere and principal component analysis revealed 
three independent factors, reflecting relationships with teachers, relationships 
with schoolmates, and bullying/rejection. The score for adverse relations with 
teachers was obtained by adding the scores of the following three questions: “I’m 
not one of the teachers’ favourites”, “Teachers often treat me unfairly”, “Teachers 
treat me well” (reversed score). The score for relations with classmates was 
obtained by adding the scores of the following three questions: “Classmates 
reckon with me”, “Our class is like-minded”, “I have a lot of friends at school” 
and “I feel secure at school”. The score for bullying/rejection was obtained by 
adding the scores of the following three questions: “I am bullied by my class-
mates”, “I feel lonely at school”, “I’m afraid of going to school”. Items were 
presented in terms of 4-point Likert scale. To obtain an overall score of school 
adversity the relationships with classmates subscale was reversed. 
Social interactions in the family were measured by Tartu Family Relation-
ships Scale (Paaver et al. 2008) which is a child-report scale. It was composed 
for ECPBHS and has four subscales: Closeness (15 items, e.g., “Our family is 
dedicated to each other”, “The marriage of my parents is happy”), Support (7 
items, e.g., “My family supports me”, “Someone in the family helps (has helped) 
me to feel important and special”), Misprize (10 items, e.g., “I can make no 
decision on my own”, “I am depreciated at home”), and Abuse (emotional and 
physical, 7 items, e.g., “Were you ever hit by someone in your family or have you 
experienced physical violence in your family?”). Items were presented in terms 
of 4- or 5-point Likert scale. At age 15, only questions later forming the 
Misprize subscale was administered to the older cohort. At age 18, all the four 
subscales were used.  
 
 
3.2.7. Anxiety 
The Spielberger State Trait Anxiety Inventory (STAI, Spielberger et al. 1983) 
was used to measure anxiety (Paper II). In the younger birth cohort, the Spiel-
berger State Anxiety Inventory (STAI-S) was used at ages 15 and 18 and the 
Spielberger Trait Anxiety Inventory (STAI-T) at age 18. In the older birth 
cohort, STAI-S was used only at age 25, and STAI-T at ages 18 and 25. 
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3.2.8. Depressiveness 
Depressiveness was measured using the self-report version of the Montgomery-
Åsberg Depression Rating Scale (MÅDRS; Montgomery and Åsberg 1979) or 
Beck Depression Inventory (BDI; Beck et al. 1961) (Paper II). BDI was used 
to measure depressiveness in the younger birth cohort at age 15. MÅDRS was 
used in the younger cohort at age 18 and in the older birth cohort at ages 18 and 
25. 
 
 
3.2.9. Impulsivity 
Self-reports for different facets of impulsivity were completed at ages 15 and 18 
for the younger cohort and at ages 18 and 25 for the older cohort (Paper II). 
The Adaptive and Maladaptive Impulsivity Scale, which follows the concept of 
functional and dysfunctional impulsivity (Dickman 1990) and comprises sub-
scales measuring fast decision-making and excitement seeking (functional or 
adaptive impulsivity) and disinhibition and thoughtlessness (dysfunctional or 
maladaptive impulsivity), was used (Laas et al. 2010). 
 
 
3.2.10. Big Five Personality 
Personality traits of the 5-factor model (Costa and McCrae 1989) (Paper II) 
were measured by self-reports with the Estonian version of Revised NEO Perso-
nality Inventory (NEO-PI-R) (Kallasmaa et al. 2000), EE.PIP-NEO (Mõttus et 
al. 2006), which is a semantically simplified 240-item version of the Inernational 
Personality Item Pool (IPIP), which emulates the NEO-PI-R, Short Five (S5) 
(Konstabel et al. 2011), which is a short inventory of five-factor personality, or 
Estonian Brief Big Five Inventory (EBBFI), which is a short and semantically 
simplified questionnaire (Harro et al. 2009, Laidra et al. 2006). All scales measure 
each of the FFM personality dimensions (Neuroticism, Extraversion, Openness 
to experience, Agreeableness and Conscientiousness), and their six subscales with 
the exception of EBBFI. All four instruments have been found to provide realistic 
and convergent assessment of personality according to the five-factor model 
(Konstabel et al. 2011, Laidra et al. 2006, Mõttus et al. 2006). Personality data 
were collected at age 15 (younger cohort: EE.PIP-NEO; older cohort: EBBFI), 
18 (younger cohort: S5; older cohort: NEO-PI-R) and 25 (older cohort: EE.PIP-
NEO). 
 
 
3.2.11. Genotyping 
Genomic DNA was extracted from venous blood samples using Qiagen 
QIAamp® DNA Blood Midi Kit.  
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3.2.11.1. 5-HTTLPR VNTR 
Genotyping for triallelic classification (Paper I) was performed according to 
Anchordoquy et al. (2003). Genotyping was done in two stages. First all subjects 
were genotyped for the 5-HTTLPR VNTR polymorphism, then SNP rs25531 
(A/G). The polymorphic region was amplified using the primers 5-HTTLPR-F: 
5′-6FAM-ATG CCA GCA CCT AAC CCC TAA TGT-3′ and 5-HTTLPR-R: 
5′-GGA CCG CAA GGT GGG CGG GA-3′. PCR reaction components and 
final concentration were as follows: 1 x of 5x HOT FIREPol BLEND with BSA 
2.5 mM MgCl2 (Solis Biodyne); 5% of DMSO; 1 x of 10x Solution S (Solis 
Biodyne); 380 μM each of the forward and reverse primers; 10–50 ng of 
template DNA. The amplification was conducted in a total volume of 20 μl. The 
touchdown PCR cycles were used as by Anchordoquy et al. (2003). The electro-
phoresis was made on ABI PRISM 3130XL genetic analyser and the compo-
nents used were: 1 μl PCR product, 10 μl Hi-Di formamide, 0.25 μl LIZ 500 size 
standard. For genotyping of SNP rs25531 (la/lg) the MspI restriction analysis 
was conducted in a total volume of 10 μl (2 μl of PCR product and 8 μl of 
restriction master mix). The reaction components and final concentrations of the 
restriction master mix were as follows: 1 x Buffer Tango; 4 units of MspI 
restriction enzyme (Fermentas). Samples were then incubated on 37 °C for 3 h 
and on 65 °C for 20 min. MspI digest electrophoresis was conducted using ABI 
PRISM 3130XL genetic analyser and the components used were: 1 μl digest 
product; 10 μl Hi-Di formamide; 0.25 μl LIZ 500 size standard. Genotypes were 
generated using ABI Gene-Mapper V 4.0 software. Genotyping was performed 
blind to all phenotypic data. All DNA samples were successfully genotyped. In 
Paper I, the subjects were classified by genotype according to the transcrip-
tional activity of the 5-HTT gene (Hu et al. 2005). Due to lg allele being 
functionally equivalent to the s allele, lg alleles were grouped together with s 
alleles for the statistical analysis. 5-HTTLPR genotype frequencies were in 
Hardy–Weinberg equilibrium and shown in Table 1. 
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Table 1. 5-HTTLPR genotype and allele frequencies in the ECPBHS sample.  
 5-HTTLPR VNTR SNP rs25531/SLC6A4 
 l/l l/s s/s la lg s 
Older cohort (n=654) 211 (32%) 302 (46%) 141 (22%) 0.55 0.08 0.37 
Males (n=290) 91 (31%) 138 (48%) 61 (21%)    
Females (n=364) 120 (33%) 164 (45%) 80 (22%)    
Younger cohort 
(n=580) 
194 (33%) 290 (50%) 96 (17%) 0.58 0.08 0.34 
Males (n=277) 92 (33%) 132 (48%) 53 (19%)    
Females (n=303) 102 (34%) 158 (52%) 43 (14%)    
 
3.2.11.2. SNP polymorphisms: VMAT1 rs1390938, NRG1 rs6994992, 
OXTR rs53576 
The real-time polymerase chain reaction (RT-PCR) for genotyping the three 
SNP polymorphisms was performed using TaqMan Pre-Designed SNP Geno-
typing Assays (Applied Biosystems; Foster City, CA, USA) containing primers 
and fluorescent probes. For VMAT1 rs1390938 (Paper II), the Assay 
C___8804621_1_ was utilized; for NRG1 rs6994992 (Paper III) and OXTR 
rs53576 (Paper IV) polymorphisms, the Assays C_____22019_10 and 
C___3290335_10 were used, respectively. Genotyping reactions were performed 
in a total volume of 10 ml with ~25 ng of template DNA. RT-PCR reaction com-
ponents and final concentrations were as follows: 1:5 5 x HOT FIREPol® Probe 
qPCR Mix Plus (ROX) (Solis BioDyne) and 1:20 80 x TaqMan Primers Probe. 
Context sequences [VIC/FAM] were as follows:  
VMAT1 rs1390938 – AGCAAACAGAACCCCGACCCGGGTA[A/G]TCTCTT 
CCTCCAAGAAACCTGTGCC, 
NRG1 rs6994992 – AAGCACCATGCAGGGTTCAAGTGAA[C/T]GTATACT 
GGAGGCCAGACCTGCCCA, 
OXTR rs53576 – AAAGGTGTACGGGACATGCCCGAGG[A/G]TCCTCAGT 
CCCACAGAAACAGGGAG. 
Reactions were performed on the Applied Biosystems ViiA™ 7 Real-Time 
PCR System. The amplification procedure consisted of an initial denaturation 
step at 95 °C for 12 min and 40 cycles of 95 °C for 15 s and 60 °C for 1 min. Pos-
itive and negative controls were added to each reaction plate. No inconsistencies 
occurred. Genotyping was performed blind to all phenotypic data. Allele fre-
quencies agreed with National Center for Biotechnology Information database 
and published reports. All DNA samples but one (younger cohort, males, VMAT1 
rs1390938) were successfully genotyped. In Paper III, NRG1 rs6994992 CT 
heterozygotes and TT homozygotes were grouped together for data analysis as 
T allele carriers due to functional similarity (Barnes et al. 2012). Other geno-
types (VMAT1 rs1390938, OXTR rs53576) were grouped based on their allelic 
variances. All genotype frequencies were in Hardy–Weinberg equilibrium and 
are shown in Table 2.  
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3.3. Statistical analysis 
Three-way analysis of variance (ANOVA) considering all interactions was 
utilized in the statistical analysis of age of first alcohol consumption (Papers I, II 
and III). Preplanned comparisons of cohorts by genotype and gender, genders by 
genotype and cohort, and genotypes by gender and cohort were performed using 
properly defined contrasts. In the same way, average values of genders by cohort 
and cohorts by genders were compared. To test the statistical significance of 
genotype × gender interactions by cohort for both cohorts, two-way ANOVA was 
performed; to test the overall genotype effect by cohort and gender, one-way 
ANOVA was used. The same methodology was applied when analyzing sub-
stance consumption frequency (Papers I–IV) and anxiety, depressiveness, im-
pulsivity and personality scores (Paper II). Additionally, the repeated measure-
ments of the same subjects were considered in three-way ANOVA. Results have 
been presented as F-statistic and raw p value. Fisher’s least significance dif-
ference method was used in post hoc comparisons.  
In the case of a dichotomous dependent variable (e.g., alcohol use disorder), 
Pearson’s chi-square (χ2) test or binary logistic regression with Wald chi-square 
ascertaining whether a variable is a significant predictor of the outcome was 
utilized, and results are reported in the form of odds ratios (OR) with confidence 
intervals (CI) (Papers II–IV). Binary logistic regression with Wald chi-square 
was also utilized when assessing the interaction of the number of stressful life 
events (Paper III) or unfavourable social interactions (Paper IV) and genotype 
on the prevalence of AUD or drug use.  
In the study on the OXTR genotype (Paper IV), we tested a series of models 
with Bayesian estimation using Markov chain Monte Carlo (MCMC) sampling 
with SPSS AMOS in order to test the mediation and interaction effects of the 
genotype, alcohol use frequency and unfavourable relations with teachers on the 
occurrence of AUD. All the continuous variables were centered, and interaction 
terms were residual-centered to avoid statistical interference errors (Little et al. 
2006). Both the direct and indirect effects were reported as standardised reg-
ression weights with 95% confidence intervals (CI), the association was regarded 
significant if the 95% CI did not cross zero. Models were evaluated by posterior 
predictive p values (ppp; the closer the ppp-value to 0.5 the better the model); 
posterior shapes, traces and autocorrelations; checked for impossible estimand 
values and non-normality; and compared with preliminary analyses presented in 
results. 
As the personality data have been collected with different instruments (Paper 
II), all scores were transformed into Z-scores for statistical analysis. In addition, 
self-reported alcohol use frequencies were transformed into Z-scores in Paper 
IV due to the variations in the number of choice items between different time 
points. Linear mixed model (LMM) was used to assess the effect of the geno-
type on changes in alcohol consumption over the three measurement times, and 
presented as numerator degrees of freedom (df) and denominator df in paren-
theses, F-statistic, and raw p-value. 
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Contrasts were calculated for significant model effects. All p values are 
reported as 2-tailed, and results are considered significant at the p<0.05 level. 
Statistical analyses were performed using IBM® SPSS® Statistics (versions 19 
and 20) and R (version 3.1.1., package “stats”). 
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4. RESULTS AND DISCUSSION 
4.1. Alcohol use in the ECPBHS sample (Papers I–IV) 
In the current population-representative birth cohort study in a CEE country, the 
subjects of the younger cohort reportedly started consuming alcohol at an earlier 
age (F[1, 1063]=84.9, p<0.001) (Figure 1). Male subjects started consuming 
alcohol statistically significantly earlier than females in the older birth cohort 
(F[1, 579]=14.6, p<0.001), and also on a trend level in the younger cohort (F[1, 
490]=2.0, p=0.158). This is similar to what has been described in the WHO 
Health Behaviour in School-Aged Children (HBSC) study reports that also 
include data from Estonia – the gender gap in alcohol use is narrowing (Currie 
et al. 2000, 2004, 2008; Pärna et al. 2012). 
 
 
Figure 1 The effect of gender and birth cohort on the average age when the subjects 
first consumed half a unit of alcohol. The dashed lines indicate the mean age when the 
subjects from the respective cohort first consumed half a unit of alcohol. N represents 
the number of subjects. Vertical bars denote standard deviations. Significant differences 
between groups: ***p<0.001.  
 
Higher alcohol consumption among individuals reporting earlier drinking onset 
has been shown in population-representative studies (Lee et al. 2012; York et al. 
2004), so such a change in drinking behaviour of the population can bear public 
health consequences. Indeed, individuals who have reported an early age of 
drinking onset have much more likely been found to meet the criteria for life-
time alcohol abuse and dependence (Grant and Dawson 1997). The lower mean 
age when the subjects reportedly first consumed half a unit of alcohol also 
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increased the likelihood of developing AUD in the ECPBHS sample 
(OR=1.15[1.08–1.23], p<0.001). There were significantly more subjects diag-
nosed with AUD by age 25 in the younger cohort (Figure 2), who, as mentioned 
previously, reportedly started consuming alcohol at an earlier age. The notion 
that the tendency of more recent birth cohorts to start consuming alcohol at an 
earlier age places them at a greater risk of developing alcohol use disorders was 
thus confirmed also in the present study. 
 
 
Figure 2 Lifetime Prevalence of AUD assessed at age 25 in the ECPBHS sample. The 
dashed lines indicate the mean proportions of subjects in the respective cohorts. N 
represents the number of subjects in the group (100%). Significant differences between 
groups: *p<0.05, ***p<0.001.  
  
Male subjects from both cohorts were more frequent alcohol consumers both at 
the age of 18 and at the age of 25. At age 15, the younger cohort was using 
alcohol more frequently than the older cohort (F[1, 1032]=59.1, p<0.001). Self-
reported alcohol use frequency was not, however, statistically significantly dif-
ferent between the cohorts at ages 18 (F[1, 891]=0.23, p=0.63) nor 25 (F[1, 
961]=0.87, p=0.35). Higher frequency of consuming alcohol (according to the 
most frequently consumed type of alcohol) increased the likelihood of lifetime 
AUD by the age of 25 in both older (Figure 3) and younger birth cohort (Figure 
4). Subjects who had had AUD by age 25 had reported higher frequency of 
consuming alcohol at the age of 15 (OR=1.45[1.16–1.81], p=0.001 and 
OR=1.60[1.21–2.10], p=0.001, for the older and younger cohort, respectively), 
18 (OR=2.02[1.37–2.97], p<0.001 and OR=2.26[1.61–3.18], p<0.001, for the 
older and younger cohort, respectively) and 25 (OR=1.79[1.35–2.38], p<0.001 
and OR=2.43[1.76–3.36], p<0.001, for the older and younger cohort, respectively).  
 
Figure 3. Frequency of consuming alcohol and the occurrence of lifetime AUD 
assessed at the age of 25 in the older birth cohort. Alcohol use frequency is according to 
the most frequently consumed type of alcohol. A five point scale was used at ages 18 
and 25: 1=never, 2=less than once a month, 3=at least once a month, 4=at least once a 
week, 5=every day. At age 15, a four point scale was used, excluding the option 
5=every day. N represents the number of subjects in the group. The dashed line 
indicates the mean frequency in the group. Vertical bars denote standard deviations. 
Significant differences between groups: *p<0.05, **p<0.01, ***p<0.001, #p=0.056. 
 
Figure 4. Frequency of consuming alcohol and the occurrence of lifetime AUD 
assessed at the age of 25 in the younger birth cohort. Alcohol use frequency is according 
to the most frequently consumed type of alcohol. A five point scale was used: 1=never, 
2=less than once a month, 3=at least once a month, 4=at least once a week, 5=every 
day. N represents the number of subjects in the group. The dashed line indicates the 
mean frequency in the group. Vertical bars denote standard deviations. Significant 
differences between groups: *p<0.05, **p<0.01, ***p<0.001, #p=0.07. 
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The number of SLEs reported at age 15 did not have any significant effect on 
the likelihood of developing AUD. SLEs reported at age 18 however had a 
significant effect on the likelihood of having been diagnosed with AUD by age 
25 in both younger (OR=3.30[1.98–5.48], p<0.001) and older birth cohort 
(OR=2.77[1.57–4.88], p<0.001) (Figure 5). SLEs reported at age 25 affected the 
likelihood of developing AUD only in males of the older birth cohort. 
Therefore, in our sample of young adults, the life stress experienced during late 
teens was the most influential.  
 
 
Figure 5 The effect of stressful life events (SLEs) reported at age 18 on the likelihood 
of having suffered from alcohol use disorder by age 25. N represents the number of 
subjects in the group. Significant differences between groups: *p<0.05, ***p<0.001. 
 
Relationships at home and in school also significantly affected the likelihood of 
developing AUD. Subjects having suffered from AUD by age 25 reported 
higher scores of abuse in the family at age 18 in both younger (OR=1.09[1.02–
1.17], p=0.009) and older birth cohort (OR=1.10[1.03–1.16], p=0.003) (Figure 
6). In school, the quality of relationships with teachers was relevant – subjects 
having suffered from AUD by age 25 reported worse relationships with teachers 
at age 15 in both younger (OR=1.20[1.06–1.35], p=0.005) and older birth cohort 
(OR=1.26[1.12–1.42], p<0.001). In both birth cohorts, the effect was mostly 
attributable to male subjects (Figure 7). 
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Figure 6. The effect of abuse in the family reported at age 18 on the likelihood of 
having suffered from alcohol use disorder (AUD) by age 25. N represents the number of 
subjects in the group. Vertical bars denote standard deviations. Significant differences 
between groups: *p<0.05. 
 
 
Figure 7. Unfavourable relations with teachers reported at age 15 and the likelihood of 
having suffered from alcohol use disorder (AUD) by age 25. N represents the number of 
subjects in the group. Vertical bars denote standard deviations. Significant differences 
between groups: *p<0.05. 
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In sum, the subjects of the younger birth cohort (born in 1988/1989) reportedly 
started consuming alcohol at an earlier age than subjects of the older birth cohort 
(born in 1982/1983), and male subjects started consuming alcohol earlier and 
were more frequent alcohol consumers than females. There were significantly 
more subjects who had suffered from AUD by age 25 among males and in the 
younger birth cohort as a whole. Subjects having suffered from AUD by age 25 
had reported higher frequency of consuming alcohol at the age of 15, 18 and 25. 
Environmental stressors (SLEs), relationships at home and in school also signi-
ficantly affected the likelihood of developing AUD. Subjects having suffered 
from AUD by age 25 reported higher number of experienced stressful life events 
and higher scores of abuse in the family at age 18. In school, the subjects (espe-
cially boys) having suffered from AUD by age 25 had reported worse relation-
ships with teachers at age 15. 
 
 
4.2. The association of 5-HTTLPR and  
alcohol use (Paper I) 
The 5-HTTLPR genotype had a significant effect on the initiation of alcohol 
consumption when it was considered in the interaction with the gender and birth 
cohort (F5-HTTLPR × gender × cohort [2, 1063]=7.2, p<0.001) on the self-reported age of 
first consumption of alcohol (Figure 8). Female subjects with the s/s genotype 
were the latest experimenters with alcohol if they belonged to the older cohort 
(born in 1982/1983), but the youngest if to the younger cohort (born in 
1988/1989). In males, there was no significant cohort difference among the s/s 
homozygotes. Peer pressure has been more strongly associated with drinking for 
girls than it has for boys (Donovan 2002; Simons-Morton et al. 2001), and 
carriers of the short allele have been found to show increased social conformity 
(Homberg and Lesch 2011), to be more sensitive to the detection of socially 
relevant information (Lonsdorf et al. 2011), and to be more susceptible to 
environmental influences (Pluess et al. 2010). Environmental conditions and 
demands have been rather different for the two birth cohorts, and with regard to 
response with changes in alcohol use behaviour, this appears to be reflected 
most prominently in 5-HTTLPR s/s females.  
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Figure 8 The effect of 5-HTTLPR genotype in interaction with gender and cohort on 
the average age when the subjects first consumed half a unit of alcohol. The dashed 
lines indicate the mean age when the subjects from the respective cohort and gender 
first consumed half a unit of alcohol. N represents the number of subjects. Vertical bars 
denote standard deviations. Differences between cohorts by genotype and gender were 
significant after Bonferroni–Holm correction for multiple testing except for the males 
with s/s genotype. Other significant differences between groups are denoted as follows: 
*p<0.05, **p<0.01. 
 
By the age of 25, the 5-HTTLPR genotype had an effect on the frequency of 
alcohol consumption in interaction with gender in the older birth cohort  
(F 5-HTTLPR × gender [5, 520]=3.6, p=0.028) (Figure 9). Male s/s homozygotes were 
the most frequent alcohol consumers; the effect was strongest in the case of 
male subjects with the s/s genotype (F[2, 221]=3.7, p=0.028). We have previ-
ously described a similar finding in the younger cohort where subjects with the 
s/s genotype were more active alcohol users by the age of 18 (Merenäkk et al. 
2011); reanalysis of the data revealed that while there was no significant inter-
action with gender, this difference was also largely derived from the male sub-
jects. So in both cohorts, larger alcohol use is significantly associated with the s 
allele and, in particular, with the s/s genotype in males, but this difference became 
significant in the older cohort at later age. Alcohol use was lower in females, and 
while the earlier onset of alcohol consumption is significantly associated with 
increased future use also in this sample, no genotype effect has become signi-
ficant within the age constraints of the study population. Our results support the 
notion that subjects with the s/s genotype are most affected by environmental 
changes and that the genotype effect may differ between male and female sub-
jects. For the 5-HTTLPR, it would seem more appropriate to consider it a “plasti-
city variant” rather than a “vulnerability genotype” (Belsky et al. 2009), and this 
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may explain why no clear negative effects of the 5-HTTLPR genotype on the 
prevalence of AUD have been detected in the ECPBHS sample by the age of 25.  
 
 
Figure 9 The effect of 5-HTTLPR genotype on the average frequency of alcohol con-
sumption during the previous 30 days in the older cohort. A seven-point scale, described 
in 3.2.1, was used. The dashed lines indicate the mean frequency of alcohol consump-
tion in the respective age and gender. Vertical bars denote standard deviations. Dif-
ferences between groups after Bonferroni–Holm correction for multiple testing: *p<0.05, 
**p<0.01, ***p<0.001 
 
 
4.3. VMAT1 effects on alcohol use and  
mental health disorders (Paper II) 
VMAT1 genotype was associated with the average age when the subjects re-
portedly first consumed half a unit of alcohol in both younger (F[2, 488]=3.0, 
p=0.053) and older (F[2, 578]=4.2, p=0.015) birth cohorts, but in opposite 
directions (Figure 10). In the younger birth cohort, GG homozygotes were the 
first and AA homozygotes the last to start experimenting; in the older cohort, it 
was the other way around. Unlike in the case of G allele carriers, there was no 
cohort difference in the mean age when AA homozygotes started experimenting 
with alcohol. Given that peer drinking serves as a model for alcohol use 
(Milgram 2001) and socially anxious youth can be motivated to use alcohol to 
manage their anxious arousal (Blumenthal et al. 2010), one possible explanation 
could be that AA homozygotes may be less sensitive to peer pressure in this 
regard. As described before, it was found by Lohoff et al. (2014) that carriers of 
the VMAT1 hyperfunction allele (A) may be predisposed to a diminished 
cortical response to negative stimuli. Activity of prefrontal regions is a critical 
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component of regulating emotional arousal, particularly those triggered in 
response to environmental factors. 
 
 
Figure 10. The effect of VMAT1 rs1390938 polymorphism in interaction with birth 
cohort on the average age when the subjects reportedly first consumed one half a unit of 
alcohol (F VMAT1 rs1390938 * cohort [2, 1066]=6.9, p=0.001). The dashed line indicates the 
mean age when the subjects from the respective cohort first consumed half a unit of 
alcohol. N represents the number of subjects. Vertical bars denote standard errors of 
mean. Significant differences between groups denoted as follows: *p<0.05, **p<0.01. 
 
AA homozygotes of the older birth cohort were less likely to have been diag-
nosed with an affective, anxiety, and/or alcohol use disorder (Table 3) and, in 
addition, reported lower state and trait anxiety, depressiveness, maladaptive 
impulsivity, and neuroticism by young adulthood compared with G allele carriers. 
All these associations were similar for men and women. Subjects homozygous 
for the hyperfunction allele (AA, Ile/Ile; predisposed to diminished cortical re-
sponse to negative stimuli) appeared to have features supporting resiliency to 
negative emotionality and these disorders. These results are essentially con-
sistent with previous research: The A allele has been found to be associated with 
reduced connectivity in networks that show a general increased connectivity in 
alcoholics, indicating a potential protective effect (Zhu et al. 2015). It has also 
been found that the gain-of-function A allele is protective against bipolar dis-
order (Lohoff et al. 2006), and the AA homozygotes have lower STAI state and 
trait scores (Lohoff et al. 2008b). Genetic variation in plasma membrane trans-
porters (serotonin, noradrenaline, and dopamine transporters) can serve as a 
basis for inter-individual differences in brain circuits associated with affective 
behaviour (Bevilacqua and Goldman 2011). These transporters are mainly 
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involved in synaptic neurotransmitter reuptake, which contributes to the duration 
of signaling. In contrast, variation in the magnitude of signaling may be more 
closely related to mechanisms regulating synaptic neurotransmitter release 
(Lohoff et al. 2014). Efficient reuptake of the transmitter from the synaptic cleft 
through plasma membrane monoamine transporters followed by reaccumulation 
into synaptic vesicles through the VMATs constitute crucial interlinked steps of 
monoamine neurotransmission (Wimalasena 2011). 
 
Table 3 VMAT1 rs1390938 effects on the lifetime prevalence of affective, anxiety, and 
alcohol use disorders in the older birth cohort assessed at age 25. 
Psychiatric 
disorders 
Total 
(n=501) 
Main statistics 
(Pearson’s χ2) 
AA  
(n=62) 
AG 
(n=208) 
GG 
(n=231) 
Affective 
disorders 
114 (23%) χ2=(2, 
N=501)=4.86, 
p=0.088 
10 (16%) 41 (20%) 63 (27%) 
Anxiety disorders 84 (17%) χ2=(2, 
N=501)=3.85, 
p=0.146 
5 (8%) 37 (18%) 42 (18%) 
Affective or 
anxiety disorder or 
both 
152 (30%) χ2=(2, 
N=501)=4.52, 
p=0.104 
12 (19%) 63 (30 %) 77 (33%) 
Alcohol use 
disorder (AUD) 
95 (19%) χ2=(2, 
N=501)=2.15, 
p=0.341 
8 (13%) 44 (21%) 43 (19%) 
Affective, anxiety, 
and/or AUD 
214 (43%) χ2=(2, 
N=501)=6.78, 
p=0.034 
17 (27%) 94 (45%) 103 (45%)  
 
Significant differences presented in bold. 
The amino acid interchange produced by Thr136Ile polymorphism is located in 
the first luminal domain of the transporter. This region of the protein interacts 
with inhibitors and substrates (Sievert and Ruoho 1997). The first luminal loop 
of VMATs also represents a G-protein-coupled receptor that adapts vesicular 
filling (Brunk et al. 2006). 136Thr has been related to decreased monoamine 
transport in vitro. Reduced storage and release of monoamines in brain regions 
expressing VMAT1 and in adrenal medulla where VMAT1 is the major type of 
VMAT have been suggested to alter the balance of monoamine availability both 
peripherally and centrally (Khalifa et al. 2012). Such presynaptic components 
are likely part of a shared pathway of vulnerability to a range of neuropsy-
chiatric phenotypes (Lohoff et al. 2014). 
The association of VMAT1 rs1390938/Thr136Ile polymorphism with psy-
chological measures and prevalence of psychiatric disorders in the older birth 
cohort is straightforward and the findings provide a remarkably coherent picture. 
However, we cannot see a similar association in the younger birth cohort. There-
fore, we have to consider that as environmental conditions and demands have 
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been different enough for the two birth cohorts, this might have brought about a 
change in the E component of the G × E formula; in turn, such a change in 
environment indeed should be reflected in how specific gene variants relate to 
the behaviour in question, in this case, psychological measures and prevalence 
of psychiatric disorders (Harro 2010).  
 
 
4.4. NRG1 and stressful life events:  
impact on drug use (Paper III) 
The NRG1 rs6994992 variation was associated with substance use. There was a 
cohort- and gender-specific effect of NRG1 on AUD. In the older birth cohort, 
the C/C homozygous females were several times more likely to have had AUD 
than T allele carriers (OR=6.01[2.13–16.94], p=0.001). Also, SLEs reported at 
age 25 had an interaction effect with the NRG1 genotype on the occurrence of 
AUD among women, as the C/C homozygous females with greater numbers of 
SLEs were more likely to have been diagnosed with AUD by the age of 25 
(OR=2.08[1.43–3.02], p<0.001) (Figure 11). Among females carrying the T 
allele, SLEs did not affect the likelihood of developing AUD. In addition, the 
C/C homozygous females who reported exposure to SLEs were significantly 
more likely to be active smokers at age 18 (OR=0.76[0.60–0.96], p=0.019) and 
the most frequent consumers of tobacco products at age 25 (FNRG1 × gender × SLE25 
[1, 461]=7.3, p=0.007). The observed gender differences may be due to gender 
differences in stress resilience, as the psychological consequences of trauma 
exposure are worse for women (Kline et al. 2013; Tolin and Foa 2006). 
Regarding tobacco use, environmental adversities have a greater deleterious effect 
on continued abstinence and the ability to quit smoking in women (McKee et al. 
2003). 
When the older birth cohort (born in 1982/1983) was aged 15, illicit drugs 
were only just beginning to become available in most of Estonia (Paimre 2013). 
By the age of 18, the older birth cohort had caught up with the younger cohort in 
prevalence of trying illicit drugs; however, differences in use between geno-
types were not significant. In the younger cohort, born six years later, drug use 
was much more prevalent by the age of 15, and male C/C homozygotes were 
the leaders in drug use, remaining so three years later. Male C/C homozygotes 
of the younger birth cohort were twice as likely to have tried illicit drugs 
compared with male T allele carriers at age 15 (OR=2.41[1.29–4.52], p=0.006) 
and age 18 (OR=2.16[1.20–3.88], p=0.011). In addition, the NRG1 genotype 
had a significant interaction effect with SLEs on trying illicit substances among 
male subjects (of the entire sample) at the age of both 15 (OR=1.32[1.07–1.62], 
p=0.009) and 18 (OR=1.28[1.08–1.53], p=0.005), as SLEs had a larger effect in 
C/C homozygotes. 
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Figure 11 The effect of NRG1 rs6994992 genotype and interaction with SLEs on the 
occurrence of AUD in the older birth cohort by the age of 25 (OR=1.49[1.23–1.81], 
p<0.001). N represents the number of subjects in the whole sample (100%). Significant 
differences between groups: ***p<0.001, #p=0.05. 
Because originally the NRG1 T allele was associated with mental health prob-
lems, the higher prevalence of all kinds of drug issues in the C/C homozygotes 
may at first appear surprising. Indeed, the C allele has been associated with 
higher working memory capacity (Stefanis et al. 2007), lower risk of developing 
psychotic illness, and higher premorbid IQ in samples at risk for psychosis (Hall 
et al. 2006; Keri et al. 2009a). Functional MRI studies have shown increases in 
frontal lobe activation associated with T homozygote status (Hall et al. 2006; 
Mechelli et al. 2009, 2010), with the interpretation that neural processing is more 
effective in C allele carriers (Barnes et al. 2012). One speculative interpretation 
is that the C/C individuals may be more open to environmental influences, both 
positive and negative. We found that higher exposure to SLEs brought about a 
further increase in the prevalence of substance use in C/C homozygotes. T allele 
carriers seem to be more resilient in this regard: adverse life events did not elevate 
the measures of substance use in this group. Indeed, T/T homozygosity has 
previously also been found advantageous in studies on community samples: 
children with the T/T genotype had better episodic memory performance in late 
adolescence (Douet et al. 2014), and among people with high intellectual and 
academic performance, the highest creative achievements and creative thinking 
scores were in T/T homozygotes (Keri 2009). Higher resilience to substance use 
in carriers of the gain-of-function T allele is consistent with animal experiments 
that have suggested higher sensitivity to cannabinoids in mice with lower 
expression of Nrg1 (Boucher et al. 2007a, 2007b). 
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4.5. Variation in the OXTR gene and  
alcohol abuse (Paper IV) 
The OXTR rs53576 polymorphism was associated with alcohol use and pre-
valence of AUD in the older cohort of the ECPBHS sample and the effects varied 
by gender. The frequency of alcohol use measured at ages 15, 18, and 25 was 
significantly affected by the interaction of OXTR rs53576 genotype and gender 
(LMM; F OXTR*gender [3, 694]=19.8, p<0.001). In males, the AA homozygotes 
(the genotype presumably with the least efficient oxytocinergic neurotrans-
mission) were the most frequent alcohol consumers at ages 15 and 18. By the 
age of 25, the frequency of alcohol use was similar for all genotypes (Figure 
12). In females and subjects of the younger birth cohort, the OXTR genotype did 
not affect the levels on alcohol use either over time. 
 
 
Figure 12 The effect of OXTR rs53576 genotype on the frequency of consuming 
alcohol (according to the most frequently consumed type of alcohol) in male subjects of 
the older birth cohort at ages 15, 18, and 25 (LMM results of three measurement times 
regarding OXTR effect on alcohol use: FOXTR[2, 314]=3.9, p=0.021). A five point scale 
was used at ages 18 and 25: 1=never, 2=less than once a month, 3=at least once a 
month, 4=at least once a week, 5=every day. At age 15, a four point scale was used, 
excluding the option 5=every day. N represents the number of subjects in the group. 
Vertical bars denote standard deviations. Post hoc: Fisher's least significant difference 
(LSD). Significant differences between groups: *p<0.05, **p<0.01, #p=0.06. 
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OXTR rs53576 genotype also had a gender-specific effect on lifetime AUD 
assessed at age 25 in the older birth cohort (Figure 13): AA homozygous males 
were significantly more likely to have had alcohol abuse or addiction than male 
G allele carriers (OR=2.89[1.24–6.72], p=0.014). Earlier findings have sup-
ported the notion that the disproportionate risk for dysfunction in males has a 
gender-related neural basis. There are distinct gender differences in alcohol use. 
As reviewed by Erol and Karpyak (2015), more women are lifetime abstainers, 
drink less, and are less likely to engage in problem drinking, develop alcohol-
related disorders or alcohol withdrawal symptoms; however, women drinking 
excessively develop more medical problems. Biological factors, including dif-
ferences in alcohol pharmacokinetics as well as its effect on brain function and 
the levels of sex hormones may contribute to some of those differences. The 
disproportionate risks are likely to have gender-related neural basis, and these 
could in part be mediated by OXTR. Using multimodal neuroimaging in a large 
sample of healthy human subjects, Tost et al. (2010) identified genotype-
dependent differences in brain structure, brain function, and personality. Specifi-
cally, the A allele carriers showed a significant allele load-dependent decrease in 
gray matter volume in the oxytocinergic ‘core’ of the brain, the hypothalamus, a 
finding that predicted reduced reward dependence in males. The subsequent 
cross-correlation of voxel-based morphometry and personality questionnaire 
measures confirmed that lower hypothalamic volumes predicted lower sociality 
in male, but not in female subjects. Furthermore, a genetic effect on the struc-
tural connectivity of the hypothalamus was indicated, which showed a strong 
increase in the correlation of the gray matter volume of the hypothalamus and 
that of the dorsal anterior cingulate gyrus and amygdala in OXTR A allele 
carriers. Male carriers of the A allele were characterized by an increase in the 
right amygdala volume which was negatively correlated with pro-social tem-
perament scores. Additionally, in a study by Wang et al. (2013) the AA homo-
zygous individuals showed lower local functional connectivity density in the 
hypothalamus and weaker resting-state functional connectivity between the 
hypothalamus and left dorsolateral prefrontal cortex, and these differences were 
again only found in males. 
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Figure 13 OXTR rs53576 genotype and occurrence of AUD by the age of 25 in the 
older birth cohort (χ2OXTR*gender=[2, N=501]=32.09, p<0.001). N represents the number of 
subjects in the group. Significant differences between groups: *p<0.05. 
 
Oxytocin has been suggested as a potential treatment for alcoholism: In a study 
of alcoholics in inpatient setting, oxytocin effectively decreased both alcohol 
craving and withdrawal symptoms (Pedersen et al. 2013). Efficacy of oxytocin 
for decreasing ethanol intake has also been shown in animal models (Kovacs et 
al. 1998; MacFadyen et al. 2016; Peters et al. 2013). Effective treatments pro-
moting recovery from addictions appear to incorporate a factor that comprises a 
form of social rehabilitation or social reintegration. Oxytocin may amplify the 
reinforcing properties of social engagement, perhaps priming social reward 
rather than providing the reward itself (McGregor and Bowen 2012). In a study 
by Young et al. (2014), it was demonstrated that oxytocin administration restores 
social bonding in drug-exposed animals. It was further elaborated that the largely 
conserved role of oxytocin in social behaviour across species (Meyer-Linden-
berg et al. 2011) and the evidence of altered oxytocinergic systems in human drug 
users (Light et al. 2004) support the potential of the oxytocinergic system as a 
neural target for the pharmacological treatment of social deficits in addiction. 
Indeed, insufficient interpersonal skills appear as a potential contributory 
factor in developing AUD in the older cohort of the ECPBHS sample. The asso-
ciation was similar for men and women. AA homozygotes who had scored 
higher in the Unfavourable School Relationships Scale at age 15 were more 
likely to develop AUD by age 25 (χ2=[2, N=438]=7.64, p=0.022). This effect 
was mainly attributable to unfavourable relations with teachers (Figure 14) even 
though there was a similar trend regarding bullying (χ2=[2, N=448]=5.48, 
p=0.065). However, unfavourable relations with classmates did not have a 
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facilitative role in the association of the OXTR rs53576 polymorphism and 
alcohol use, nor did social interactions in the family. As AA homozygotes re-
portedly have lower general sociality (Li et al. 2015), empathy and self-esteem 
(Saphire-Bernstein et al. 2011), and higher levels of stress reactivity (Rodrigues 
et al. 2009), their probability to develop interpersonal problems or even get 
victimized at school may be higher (Crawford and Manassis 2011). The AA 
homozygotes have also been found to seek less emotional support during stress 
(Kim et al. 2010) and be less able to benefit from social support (Chen et al. 
2011). Another study has found A allele carriers less likely to adopt problem-
focused strategies in the face of unsupportive interactions (McInnis et al. 2015). 
Victimization at school consistently predicts higher alcohol consumption and 
problematic drinking (Rospenda et al., 2013), as victimized adolescents are 
likely to adopt a drinking style to cope (Archimi and Kuntsche 2014). In turn, 
drinking to cope is associated with a higher risk of alcohol-related problems 
(Kuntsche et al. 2005). Therefore, if AA homozygous subjects do not obtain 
adaptive coping methods or communications skills already in adolescence, they 
might be more prone to develop AUD. 
 
 
Figure 14 The relationship between OXTR rs53576 genotype, likelihood of AUD 
diagnosis by age 25 and unfavourable relations with teachers at age 15 (χ2=[2, 445]=9.15, 
p<0.01). N represents the number of subjects. Vertical bars denote standard deviations. 
Significant differences between groups: *p<0.05; **p<0.01; ***p<0.001. 
 
 
 
44 
Based on the previous analyses, we tested both mediation and interaction models 
(Baron and Kenny 1986) with Bayesian MCMC sampling for predicting AUD 
with genotype, alcohol use frequency and unfavourable relations with teachers. 
All the tested models converged; there were no negative (impossible) variances, 
and posterior distributions were statistically and visually appropriate. We tested 
the models separately in males and females of the older birth cohort as previous 
results had indicated gender differences, starting from the models where both 
relations with teachers and alcohol use were modeled both as mediators and 
moderators of OXTR effects on AUD. As the model fit was poor in both genders 
(ppp˂0.01), we continued with models where moderation and mediation effects 
were varied in addition to direct effects. Figure 15 presents the final reduced 
models (ppp-value for males 0.29 indicating a good fit, and for females, ppp=0.01 
indicating modest fit). OXTR x Alcohol use interaction term and unfavourable 
relations with teachers at age 18 were omitted from this model as the interaction 
term was not a significant predictor and relations at age 18 was a weaker pre-
dictor compared to relations reported at age 15. So, in males of the older birth 
cohort, OXTR genotype exerted its effects on the developing of AUD both 
indirectly via alcohol use in adolescence and by interacting with unfavourable 
relations with teachers. The direct effect of OXTR on AUD in a similar model 
was not significant: males, 0.090 (–0.088; 0.264); females, 0.020 (–0.117; 0.137). 
In females, OXTR influenced AUD by interacting with unfavourable relations 
with teachers at age 15, not via alcohol use. In the older birth cohort as a whole, 
the only direct significant genotype-related predictor was Genotype × Unfa-
vourable relations with teachers at age 15 [interaction term 0.198 (0.069; 0.333); 
ppp=0.01]. In all the models, alcohol use both at ages 15 and 18 contributed 
significantly to AUD. According to the summary model of developing AUD, the 
moderating effect of unfavourable relations was independent of the mediating 
effect of alcohol use in both male and female rs53576 AA homozygotes. Even 
though interpersonal relations and alcohol use behaviour in teens are thought to 
be interweaved, the association between drinking frequency and relations with 
teachers at the same time point was weak while statistically significant (at age 
15 r=0.128, p=0.002; and at age 18 r=0.190, p˂0.001) indicating that they do 
not greatly overlap in time. So, according to the final model, for the AA homo-
zygotes, there could be two different pathways starting from adolescence that 
could lead to AUD: the first via more frequent alcohol use and the second by 
interacting with insufficient interpersonal skills, especially with teachers. 
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Figure 15 Predicting AUD with OXTR, alcohol use frequency and unfavourable 
relations with teachers in the final SEM model. Results are given separately for males 
(M) and females (F) as standardized direct (solid arrows) and indirect (dashed and 
curved arrows) effects with 95% CI. The direct effects from one variable straight to 
another show that male AA homozygotes use alcohol more frequently at age 15, 
subjects who are more frequent alcohol users at age 15 are more frequent alcohol users 
at age 18, and subjects who use alcohol more frequently at age 18 more likely develop 
AUD. Additionally, while relations with teachers has itself a direct effect, both sexes 
with the AA genotype who have unfavourable relations with teachers develop AUD 
more often (moderator Genotype x relations effect). Indirect effects of OXTR describe 
the pathways via where alcohol use variables are mediators: Male AA homozygotes use 
alcohol more frequently and the effect of OXTR on alcohol use at age 18 and AUD are 
exerted via alcohol use at earlier ages (mediation effects). Results come from SEM 
model with Bayesian estimation using MCMC sampling. Model ppp-value for males is 
0.29 and for females 0.01. 
 
The role that oxytocin plays in animal models in driving the formation of 
attachments between conspecifics has led to the hypothesis that oxytocin can act 
on the brain’s reward circuits by facilitating the release of dopamine by ventral 
tegmental area (VTA) neurons into the nucleus accumbens (Mitchell et al. 
2015). Indeed, it has been shown in rodents that oxytocin dose-dependently 
excites dopamine neurons in the VTA (Tang et al. 2014), and oxytocin infusion 
into the prelimbic cortex alters dopamine levels in accumbens (Young et al. 
2014). Using an oxytocin analog carbetocin and viral-mediated overexpression 
of the oxytocin receptors in nucleus accumbens it was shown that both oxytocin 
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receptor stimulation and overexpression globally suppresses the rewarding 
properties of ethanol in mice (Bahi 2015). In a study on opiate tolerance and 
dependence by Sarnyai and Kovács (1994) it was demonstrated that chronic 
oxytocin treatment decreased the number of apparent binding sites of dopamine 
in the basal forebrain area and also inhibited a cocaine-induced increase in 
dopamine utilization in the nucleus accumbens. It was concluded that oxytocin 
may act as a neuromodulator on dopaminergic neurotransmission in limbic-
basal forebrain structures to regulate adaptive CNS processes leading to drug 
addiction, at least in animal models. 
 
 
4.6. Conclusions 
In the current population-representative birth cohort study in an CEE country, 
the subjects of the younger birth cohort (born in 1988/1989) reportedly started 
consuming alcohol at an earlier age than subjects of the older birth cohort (born 
in 1982/1983), and male subjects started consuming alcohol earlier and were 
more frequent alcohol consumers than females. There were significantly more 
subjects diagnosed with AUD at some point of their life by age 25 among males 
and in the younger birth cohort as a whole. Subjects who had had AUD by age 25 
had reported higher frequency of consuming alcohol at the age of 15, 18 and 25.  
Environmental stressors (SLEs), relationships at home and in school also 
significantly affected the likelihood of developing AUD. The number of experi-
enced stressful life events and the abuse in the family reported at age 18 had a 
significant effect on the likelihood of having been diagnosed with AUD. In 
school, the quality of relationships with teachers was relevant, especially for 
boys – the worse relationships the students reported at age 15, the higher the 
likelihood of having been diagnosed with AUD. 
5-HTTLPR genotype had a significant effect on alcohol consumption, but 
the association was different in the two birth cohorts, suggestive of the signi-
ficance of gene–environment interactions. Female subjects with the s/s genotype 
were the latest experimenters with alcohol if they belonged to the older cohort, 
but the youngest if to the younger cohort. In the older birth cohort, male s/s 
homozygotes were the most frequent alcohol consumers by the age of 25; in the 
younger cohort, male subjects with the s/s genotype were more active alcohol 
users by the age of 18. Our results support the notion that subjects with the s/s 
genotype are most affected by possible environmental changes and that the 
genotype effect may differ between male and female subjects. Therefore, for  
5-HTTLPR, it would seem more appropriate to consider it a “plasticity gene” 
variant rather than of a “vulnerability gene” (Belsky et al. 2009), and this may 
explain why no overt negative effects of early alcohol use have been detected in 
the ECPBHS sample by the age of 25.  
We found the VMAT1 rs1390938/Thr136Ile polymorphism to be associated 
with lifetime prevalence of affective, anxiety, and alcohol use disorders, but, 
again, in a cohort-specific manner. Subjects of the older birth cohort homozygous 
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for the hyperfunction allele (AA, Ile/Ile; predisposed to diminished cortical 
response to negative stimuli) appeared to have features supporting resiliency to 
negative emotionality and these disorders. Genetic variation in plasma membrane 
transporters (serotonin, noradrenaline, and dopamine transporters) can serve as 
a basis for inter-individual differences in brain circuits associated with affective 
behaviour (Bevilacqua and Goldman 2011). These transporters are mainly 
involved in synaptic neurotransmitter reuptake, which contributes to the duration 
of signaling. In contrast, variation in the magnitude of signaling may be more 
closely related to mechanisms regulating synaptic neurotransmitter release 
(Lohoff et al. 2014). Efficient reuptake of the transmitter from the synaptic cleft 
through plasma membrane monoamine transporters followed by reaccumulation 
into synaptic vesicles through the VMATs constitute crucial interlinked steps of 
monoamine neurotransmission (Wimalasena 2011). 
NRG1 variant rs6994992 (SNP8NRG243177) affected substance use and the 
relationship was moderated by adverse life events. It appears that in a general 
population, the C/C homozygotes, especially those who had experienced a 
higher number of SLEs, had more often developed AUD by young adulthood 
and either were generally more active consumers of tobacco products (older 
birth cohort) or had more likely used illicit drugs (younger birth cohort). Based on 
previous studies, we have offered an interpretation that the C/C individuals may 
be more open to environmental influences, both positive and negative. T allele 
carriers seem to be more resilient in this regard: adverse life events did not 
elevate the measures of substance use in this group. 
The OXTR rs53576 polymorphism was found to be associated with alcohol 
use and prevalence of alcohol use disorders in the older birth cohort; the effects 
varied by gender and quality of interpersonal relations. In males, the AA 
homozygotes (the genotype associated with the least efficient oxytocinergic 
neurotransmission, lower general sociality and higher levels of stress reactivity) 
were the most frequent alcohol consumers and more likely to have had alcohol 
abuse or addiction. Furthermore, the AA homozygotes who reported more un-
favourable relations at school at age 15 were more likely to develop AUD by 
age 25. Therefore, if AA homozygous subjects do not obtain adaptive coping 
methods or communications skills already in adolescence, they might be more 
prone to develop AUD. 
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5. CLOSING REMARKS 
With this dissertation we have contributed to substance use research by demon-
strating in a population-representative sample the effects of specific common 
genetic polymorphisms on substance use and that genetic factors that influence 
liability to substance use are systematically dependent on birth cohorts and other 
environmental factors. 
When analyzing the effects of common genetic polymorphisms (5-HTTLPR 
VNTR, VMAT1 rs1390938, NRG1 rs6994992, OXTR rs53576) in general popu-
lation on alcohol use and abuse, the genotypes associated with higher levels of 
stress reactivity, openness to environmental influences and affectability by 
environmental changes seem to be the ones also linked to problematic alcohol 
use. However, the relations strongly depend on birth cohort as a proxy for the 
socioeconomic environment experienced by different generations. A study 
investigating societal-level disapproval of drug use (marijuana) defined by birth 
cohort or by time period documents that adolescents who mature in birth cohorts 
with low disapproval of drug use are at higher risk of using drugs during their 
teenage years, regardless of individual-level disapproval, perceived social norms, 
or perceived availability (Keyes et al. 2011b). It is deduced that social norms 
and attitudes regarding drug use cluster in birth cohorts, and this clustering has 
a direct effect on drug use even after controlling for individual attitudes and 
perceptions of norms. The finding that drug use is predicted by a cohort effect 
rather than a period effect is figured to suggest that adolescents are more 
influenced by individuals of similar age than by broad socio-cultural influences 
that affect all adolescents simultaneously (e.g., policy and law changes).  
Variation in substance abuse liability stems not only from genotypic dif-
ferences and environmental circumstances but also from their interactions: it 
occurs when the expression of a gene varies in different environments, or at dif-
ferent ages, or when the influence of the environment varies by genotype 
(Gunzerath and Goldman 2003). As reviewed by Young-Wolff et al. (2011), there 
are two principal processes whereby environmental circumstances have been 
theorized to interact with genetic influences with respect to drinking behaviours. 
First, environmental restrictions, including social norms promoting abstinence 
and restricted availability of alcohol, are hypothesized to dampen the expression 
of genetic influences on drinking behaviours (Shanahan and Hofer 2005). In 
environments characterized by high levels of social control, a large proportion 
of individuals, irrespective of genotype, are expected to exhibit low levels of 
drinking. Conversely, in more permissive settings, people’s alcohol consumption 
will reflect the full range of their genotypes. A second mechanism is that the 
social context can act as a stressor that potentiates the behavioural expression of 
genetic liability on risk for alcohol consumption and AUDs. In effect, this renders 
individuals with genetic risk even more sensitive to the pathogenic effects of 
environmental stressors (Rende and Plomin 1992). Interestingly, in a study by 
Brun et al. (2009), more genetically influenced traits were found to be the more 
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variable phenotypes and environmental influences to be greater for the later-
developing brain regions (e.g., the frontal lobes), suggesting that often environ-
ment acts to reduce the genetically produced variability (Harro 2010). 
The rapid socioeconomic changes that have taken place in Estonia since the 
beginning of 1990s and are still ongoing affect the values, activities, relation-
ships, leisure time choices and everyday functioning of the people living in this 
transition society. Intercultural transformation processes continuously shape the 
identities and lifestyles of individuals, and, as we have demonstrated with this 
dissertation, also may moderate the genetic effects on alcohol consumption. 
However, further analyses are needed to fully grasp and determine the exact 
mechanisms responsible for the different qualities observed in the two birth 
cohorts. 
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SUMMARY IN ESTONIAN 
Geenid ja alkoholitarvitamine:  
levinud geenipolümorfismide mõju rahvastikus 
Käesolevas väitekirjas uurisime suurel rahvastiku suhtes esinduslikul valimil, 
kuidas mõjutavad geneetilised faktorid (4 levinud funktsionaalset geenipolü-
morfismi), keskkondlik stress ja sünnikohort alkoholi tarvitamist ning alkoholi-
probleemide kujunemist. Leidsime, et noorema kohordi uuritavad (sündinud 
enamasti 1988/1989) alustasid alkoholi tarvitamisega varasemas eas kui vanema 
kohordi uuritavad (sündinud 1982/1983) ning meessoost uuritavad alustasid 
alkoholi tarvitamisega varem ning tarvitasid alkoholi sagedamini kui naissoost 
uuritavad. 25. eluaastaks oli alkoholiprobleeme kogenuid rohkem meeste seas 
ning nooremas kohordis tervikuna. Uuritavad, kes olid 25. eluaastaks alkoholi-
probleeme kogenud, raporteerisid 15, 18 ja 25 aasta vanuselt sagedasemat alko-
holitarvitamist. Alkoholiprobleemide kogemise tõenäosust tõstsid ka stressi-
rikkad elusündmused ning halvad suhted kodus ja koolis. 
Serotoniini (5-HT) hulk sünaptilistes piludes on reguleeritud serotoniini 
transporteri (5-HTT) poolt. 5-HTT geeni promootorpiirkond sisaldab polümor-
fismi (5-HTTLPR), millel on 2 funktsionaalset varianti – lühike ja pikk alleel. 
Lühikest alleeli on varasemalt seostatud mandelkeha suurema reaktiivsusega 
hirmutavatele stiimulitele. Oma uuringus leidsime, et 5-HTTLPR genotüüp 
mõjutab alkoholi tarvitamist, kuid antud seos erineb kohorditi, viidates geeni-
keskkonna interaktsioonile. Nimelt olid kahe lühikese alleeliga noorema kohordi 
tüdrukud kõige varasemad alkoholi proovijad, kahe lühikese alleeliga vanema 
kohordi tüdrukud aga kõige hilisemad alkoholi proovijad. Kahe lühikese 
alleeliga mehed olid kõige aktiivsemad alkoholi tarvitajad nooremas kohordis 
18. eluaastaks ning vanemas kohordis 25. eluaastaks. Meie tulemused toetavad 
seisukohta, et kahe lühikese alleeliga inimesed on keskkondlikele mõjutustele 
kõige vastuvõtvamad ning efektid võivad sugude kaupa erineda. 5-HTTLPR 
näol on seega tegemist pigem närvisüsteemi ja käitumise plastilisuse, mitte 
haavatavusega seotud polümorfismiga, mis võib seletada ka fakti, et antud 
valimis ei mõjutanud 5-HTTLPR alkoholiprobleemide esinemise tõenäosust. 
Monoamiine – serotoniini, dopamiini, adrenaliini, noradrenaliini jt – transpor-
divad tsütoplasmast säilituspõiekestesse vesikulaarsed monoamiini transporterid 
(VMAT). 1. tüüpi VMAT-i geenis leidub polümorfism rs1390938, mis tingib 
muudatuse valgu struktuuris. Antud polümorfismi A-alleel on seotud mono-
amiinide suurenenud transpordiga vesiikulitesse ning on seega n-ö hüperfukt-
siooni alleel. Meie valimis on rs1390938 polümorfism seotud ärevus- ja meele-
oluhäirete ning alkoholiprobleemide esinemissagedusega, kuid taas sõltuvad 
efektid sünnikohordist. Vanema kohordi uuritavad, kellel oli 2 hüperfunktsiooni 
alleeli, olid ärevus- ja meeleoluhäiretele ning alkoholiprobleemide eest rohkem 
kaitstud. 
Neureguliin-1 on signaalvalk, mis mõjutab neuronite arengut ja surma, 
sünaptilist plastilisust ja gliia funtsioone ning sellele on omistatud kriitiline roll 
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organismi kohanemisvõimes. Neureguliin-1 geeni promootorpiirkonnas asub 
polümorfism rs6994992 (C/T), mille C-alleeli on seostatud efektiivsema info-
töötluse, suurema töömälu mahu ja kõrgema vaimse võimekusega. Leidsime, et 
C-alleeli homosügoodid, kes olid kogenud rohkem stressirikkaid elusündmusi, 
olid 25. eluaastaks tõenäolisemalt kogenud alkoholiprobleeme, tarvitasid aktiiv-
semalt tubakatooteid ning olid suurema tõenäosusega proovinud keelatud 
uimasteid. Uuritavatel, kellel oli T-alleel, ei mõjutanud stressirikkad elusünd-
mused alkoholi, tubakatoodete ja keelatud uimastite tarvitamist. Võttes arvesse 
varasemaid tulemusi, võib põhjuseks olla C-alleeli homosügootide suurem 
vastuvõtlikkus keskkondlikele mõjutustele, nii positiivsetele kui negatiivsetele. 
Oksütotsiini – õppimise, mälu, meeleolu, paljunemise ja sotsiaalses kontekstis 
kohanemisega seotud hormooni – nasaalne manustamine on leitud avaldavat 
mõju mitmetele inimese füsioloogilistele ja psüühilistele reaktsioonidele, tuues 
teiste seas kaasa ka ärevuse ning alkoholi võõrutusnähtude vähenemise. Oksü-
totsiini nasaalse manustamise efektid on leitud olevat mõjutatud oksütotsiini 
retseptori geenis leiduva polümorfismi rs53576 (A/G) poolt. Selle A-alleeli on 
seostatud vähemefektiivse oksütotsiinergilise süsteemi, madalama sotsiaalsuse 
ja suurema reaktiivsusega stressile. Meie valimi meessoost A/A homosügoodid 
olid kõige sagedasemad alkoholitarvitajad ning nad olid nooreks täiskasvanu-
eaks kõige tõenäolisemalt kogenud alkoholiprobleeme. Lisaks olid 25. eluaastaks 
tõenäolisemalt alkoholiprobleeme kogenud need uuritavad (nii mees- kui 
naissoost), kes raporteerisid 9. klassis halbu koolisuhteid. Sellest järeldub, et kui 
A/A homosügoodid ei omanda teismeeaks kohaseid suhtlemisoskusi ega käitu-
misviise, võivad nad suurema tõenäosusega kogeda alkoholiprobleeme. Antud 
seos esines aga üksnes vanemas kohordis, viidates geenide ja keskkonna-
tingimuste interaktsioonile. 
Analüüsides levinud geenipolümorfismide mõju alkoholitarbimisele, leid-
sime, et kõrgema stressireaktiivsuse ja keskkondlike mõjude suhtes avatusega 
seonduvad polümorfismid olid ühtlasi ka need, mis seondusid probleemse alko-
holitarbimisega. Seosed sõltusid suures osas aga sünnikohordist, mis väljendab 
erinevate generatsioonide poolt kogetud sotsiaalmajanduslikku keskkonda. 
Kiired ühiskondlikud muutused, mis said alguse 1990. aastatel ning toimuvad 
praegugi, mõjutavad meie siirdeühiskonnas väärtushinnanguid, vaba aja tege-
vusi, suhteid ja igapäevast toimetulekut. Keskkondlikud piirangud, sh sotsiaal-
sed normid ja kättesaadavuse piiramine vähendavad geneetilisi mõjusid alko-
holitarbimisele. Vabamates tingimustes avalduvad geeniefektid aga ilmekamalt. 
Sotsiaalne kontekst võib toimida ka stressorina, mis võimendab geneetilisi 
eelsoodumusi. Kultuurisisesed ja ühiskondlikud muutused vormivad pidevalt 
inimeste identiteeti ja elustiili ning, nagu käesolevas väitekirjas demonst-
reeritud, võivad vahendada ka geeniefekte alkoholitarbimisele. 
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